Response by Siontis et al to Letter Regarding Article, "Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States".

Authors :: Siontis KC
Zhang X
Schaubel DE
Yao X
Noseworthy PA
Shah ND
Saran R
Nallamothu BK
Source :: Circulation [Circulation] 2019 Mar 19; Vol. 139 (12), pp. 1563-1564.
Publication Year :: 2019

Subjects :: Humans
Pyrazoles
Pyridones
United States
Atrial Fibrillation
Kidney Failure, Chronic

Full Text Access

Tools